Screener
Agilon Health AGL Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -5.2%+1.2pp | -7.5%-2.4pp | -7.8%-3.0pp | -6.4%-0.2pp | -6.4%-1.6pp | |
| Net margin | -3.9%+1.4pp | -6.1%-2.1pp | -6.6%-2.3pp | -5.2%+1.6pp | -5.3%+0.3pp | |
| Returns | ||||||
| Return on equity | -73%-14.8pp | -104%-63.3pp | -131%-85.0pp | -70%-16.8pp | -58.2%-19.8pp | |
| Return on invested capital | -171.4%-85.6pp | -214.8%-155pp | —— | -118.6%-61.5pp | -85.8%-48.2pp | |
| Efficiency | ||||||
| Asset turnover | 3.6×+0.5× | 3.4×+0.6× | 3.9×+0.5× | 3.2×+0.6× | 3×+0.7× | |
| Liquidity | ||||||
| Current ratio | 1.1×-0.1× | 1×-0.2× | 1×-0.2× | 1.1×-0.2× | 1.2×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.2×+0.1× | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $13.22-46.5% | $10.89-64.0% | $0.31-73.3% | $0.74-47.1% | $24.70+1,402% | |
| Valuation | ||||||
| Market capitalization | $1.46B+295% | $131.26M-92.6% | $285.52M-63.5% | $426.86M-73.6% | $914.83M-66.0% | |
| Price / sales | 0.3×+0.2× | 0×-0.3× | 0×-0.1× | 0.1×-0.2× | 0.2×-0.4× | |
| Price / book | 6.4×+5.5× | 0.7×-2.8× | 2.3×+0.6× | 1.4×-1.4× | 2.2×-1.7× |
FAQ
- Where do Agilon Health's ratios come from?
- Every ratio is computed from Agilon Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
